Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm Metastasis × etoposide phosphate × 30 days × Clear all

Sponsor

Conditions

Sarcoma, Ewing 2 Rhabdoid Tumor 2 Neuroblastoma 2 Medulloblastoma 2 Ependymoma 2 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Pinealoma 1 Osteosarcoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Histiocytosis, Langerhans-Cell 1 Ganglioneuroblastoma 1 Carcinoma 1 Brain Neoplasms 1

Interventions

Specimen Handling 32 Biopsy 30 Magnetic Resonance Spectroscopy 21 pembrolizumab 16 Nivolumab 10 trastuzumab deruxtecan 9 Paclitaxel 9 Pemetrexed 8 Cisplatin 8 Carboplatin 8 Taxes 7 Leucovorin 6 Irinotecan 6 Gemcitabine 6 Fulvestrant 6 Fluorouracil 6 Capecitabine 6 130-nm albumin-bound paclitaxel 6 X-Rays 5 Radiosurgery 5 Oxaliplatin 5 Ipilimumab 5 Cetuximab 5 abemaciclib 4 Trastuzumab 4 Drug Therapy 4 Doxorubicin 4 Cyclophosphamide 4 tislelizumab 3 talazoparib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡